Key result
BDNF hypermethylation is linked to suicidal ideation one year post-ACS.
Why the study?
Is BDNF hypermethylation associated with suicidal ideation in patients with acute coronary syndrome?
Cohort (n=969)
Is BDNF hypermethylation associated with suicidal ideation in patients with acute coronary syndrome?
p-value: p=0.006
BDNF hypermethylation may serve as an epigenetic marker for increased risk of suicidal ideation in patients recovering from acute coronary syndrome.
OBJECTIVE: Patients with acute coronary syndrome (ACS) are at an increased risk of suicide. It is well known that epigenetic mechanisms may explain the pathophysiology of suicidal behavior including suicidal ideation (SI), but no study has explored these mechanisms in ACS populations. METHODS: In total, 969 patients were initially recruited within 2 weeks of the acute coronary event and, 711 patients were successfully followed up 1 year after ACS. SI was evaluated using the relevant items on the Montgomery-Åsberg Depression Rating Scale and covariates potentially affecting SI were estimated. RESULTS: Brain-derived neurotrophic factor (BDNF) hypermethylation was associated with SI in both the acute and chronic phases of ACS, although the association was not statistically significant in the acute phase after applying Bonferroni's correction. CONCLUSION: These results suggested that BDNF hypermethylation may have played a role in an epigenetic predisposition for SI in ACS patients, particularly during the chronic phase.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2018) conducted a cohort in Acute Coronary Syndrome (n=969). BDNF hypermethylation vs. Lower BDNF methylation was evaluated on Suicidal ideation at 1 year post-ACS (p=0.006). Brain-derived neurotrophic factor (BDNF) hypermethylation was significantly associated with suicidal ideation at 1 year following acute coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: